HGF and cancer: Thus, it may be expected that in an immunocompetent setting our tested approach of HGF/c-MET inhibition would be even more effective since it will not only block cancer cell growth due to PSC–cancer cell interactions but will also inhibit immune suppression, thereby allowing T cell-mediated cytotoxic effects on cancer cells.